Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Topical pain reliefs are liquids, gels, powders, creams, semisolids, emulsions, patches, foams, or aerosols containing an analgesic agent applied on or around the painful site. Most topical preparations are available as patches, ointments, or creams for cutaneous applications for adult patients and children. Among the most widely known drugs with peripheral effects are nonsteroidal anti-inflammatory drugs (NSAIDs), anaesthetics, capsaicin, alpha-adrenoreceptor antagonists, and cannabinoids. Topical pain medications that stimulate nerve endings when applied to the skin are used to treat musculoskeletal pain.
The global topical pain relief market is experiencing high demand due to upsurge in geriatric population and rise in prevalence of arthritis. Moreover, high demand for topical pain relievers among athletes and lesser side effects as compared to conventional oral medicines are propelling the market growth. Also, proliferation of online pharmacy and untapped potential in emerging nations offer new opportunities to the industry. However, unpleasant odours and side effects associated with the pain reliefs are hampering the market.
The report analyses the global topical pain relief market based on type, formulation, therapeutic class, distribution channel and geography.
Based on type, the market is categorized into over-the-counter (OTC) pain reliefs and prescription pain reliefs. OTC topicals are available in pharmacies, drugstores, supermarkets or directly from the manufacturer without a doctor's prescription. They come in many different forms. Two active ingredients, salicylic acid and tar, are approved by the FDA as treatments for psoriasis.
Various formulations included in this market are cream, gel, patch, spray and others. Patch forms of local anaesthetics can be applied to the skin and may be worn for several hours for pain relief. These topical medications can relieve certain types of neuropathic pain.
Based on therapeutic class, the market is segmented into opioids and non-opioids. The opioids are further segmented into buprenorphine and fentanyl. Whereas, the non-opioids majorly comprise of capsaicin, lidocaine, methyl salicylate, nonsteroidal anti-inflammatory drugs (NSAIDS) and other non-opioids. NSAIDs are popular drugs and have widespread use for chronic and acute musculoskeletal conditions. They have the advantage of local action without developing central adverse effects and cognitive impairments.
Based on distribution channel, the market is segmented into e-commerce, pharmacies & drug stores and retail & grocery stores.
By geography, the global topical pain relief market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world regions which includes Latin America, and Middle East & Africa. North America followed by Europe will continue to dominate the global topical pain relief market in 2018. North America has surfaced as the key contributor to the global market due to Rise in prevalence of chronic diseases including cancer, arthritis, and diabetes among others coupled with increase in investments by various multinational companies. Also, the Asia Pacific is expected to exhibit significant growth over the forecast period due to increasing disposable income, shift in focus of manufacturers toward topical pain relief products, and growth in awareness among population.
The leading topical pain relief market players are AdvaCare Pharma, Chattem, Inc., Emami Group, Exzell Pharma, GlaxoSmithKline Plc., Johnson & Johnson PLC, Nestle S.A., Novartis AG, Performance Health Technologies, Inc., Pfizer Inc., Reckitt Benckiser Group Plc., Sanofi S.A., Sun Pharmaceutical Industries Ltd., Topical BioMedics, Inc. and Troy Healthcare, LLC. The growing investments in research and development of pharma industry have been encouraging the market players to offer effective solutions to gain a competitive edge in the topical pain relief market.
The global topical pain relief market is segmented based on type, formulation, therapeutic class, distribution channel and geography. Based on type, the market is categorized into over-the-counter (OTC) pain reliefs and prescription pain reliefs. Various formulations included in this market are cream, gel, patch, spray and others.
Based on therapeutic class, the market is segmented into opioids and non-opioids. The opioids are further segmented into buprenorphine and fentanyl. Whereas, the non-opioids majorly comprise of capsaicin, lidocaine, methyl salicylate, nonsteroidal anti-inflammatory drugs (NSAIDS) and other non-opioids. Based on distribution channel, the market is segmented into e-commerce, pharmacies & drug stores and retail & grocery stores.
By geography, the global topical pain relief market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and rest of the world regions which includes Latin America, and Middle East & Africa.
Why to buy this report:
